There were 326 press releases posted in the last 24 hours and 148,193 in the last 365 days.

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status

PUNE , MAHARASHTRA, INDIA, September 19, 2016 /EINPresswire.com/ -- Metastatic Ovarian Cancer Industry

Description

GlobalData's clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Ovarian Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Report Detail’s@ https://www.wiseguyreports.com/reports/644168-metastatic-ovarian-cancer-global-clinical-trials-review-h2-2016


The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/644168-metastatic-ovarian-cancer-global-clinical-trials-review-h2-2016



Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Metastatic Ovarian Cancer Therapeutics Clinical Trials 26
Prominent Drugs 28
Latest Clinical Trials News on Metastatic Ovarian Cancer 29
Jul 28, 2016: Use Of Parsortix In GANNET53 Drug Trial In Ovarian Cancer 29
Clinical Trial Profile Snapshots 30
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 104

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=644168

Continued...

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here